TcoF overview
TcoF: TLE2
GeneID: 7175
Name: Transducin-like enhancer protein 2
Ensembl: ENSG00000065717
Species: Human
Class: class HC
Family: Transducin
Disease: 0
Go term: 14
Pathway: 19
Hallmark: --
Super Enhancer:

chr19:3033610-3037135 chr19:3024493-3048496 chr19:3024468-3048100 chr19:3024965-3048279 chr19:3033393-3037121 chr19:3033328-3037990 chr19:3024830-3066658 chr19:3033460-3068681 chr19:3033629-3066290 chr19:3034655-3064141 chr19:3034080-3063599 chr19:3034005-3068577 chr19:3018910-3064260 chr19:3034310-3064076 chr19:3033934-3063764 chr19:3034135-3063766 chr19:3024313-3068716 chr19:3024280-3063948 chr19:3034368-3074383 chr19:3024084-3076605 chr19:3004903-3080108 chr19:3025139-3058337 chr19:3025019-3077180

Enhancer:

chr19:3054190-3055660 chr19:3056350-3057670 chr19:3061260-3062170 chr19:3067960-3069180 chr19:3142430-3143060 chr19:3180330-3180870 chr19:3273920-3275850 chr19:3282500-3284890 chr19:3284960-3285930 chr19:3434400-3435080 chr19:3478480-3478810 chr19:3478930-3480390 chr19:3193430-3195220 chr19:3275980-3278020 chr19:2700370-2702640 chr19:2798390-2799550 chr19:2977620-2978190 chr19:3028380-3028700 chr19:3055720-3056300 chr19:3057740-3059280 chr19:3059440-3061150 chr19:3102140-3103170 chr19:3115360-3117470 chr19:3345850-3347490 chr19:3371500-3371790 chr19:3403140-3405580 chr19:3408870-3410080 chr19:3435210-3437270 chr19:3443400-3445650 chr19:3498700-3500530 chr19:3515560-3517950 chr19:3656560-3657480 chr19:3657810-3659930 chr19:3670200-3672630 chr19:3673030-3673470 chr19:3673480-3674120 chr19:3690520-3691010 chr19:3770960-3771520 chr19:3243960-3245440 chr19:3624160-3626590 chr19:2987240-2987350 chr19:2987370-2987720 chr19:2978280-2979830 chr19:3079890-3081870 chr19:3025080-3026470 chr19:3083940-3086280 chr19:3012740-3013660 chr19:3359680-3361560 chr19:3572990-3573280 chr19:3573350-3573680 chr19:3573800-3574380 chr19:3576620-3576880 chr19:3616720-3618870 chr19:3045800-3047560 chr19:2986890-2986980 chr19:3005970-3006410 chr19:3024260-3025010 chr19:3270130-3271770 chr19:3243650-3246150 chr19:2996000-2997630 chr19:3022500-3023710 chr19:3150280-3151700 chr19:3290370-3291450 chr19:3452660-3453760 chr19:3544940-3546070 chr19:3547360-3547450 chr19:3547550-3547840 chr19:3575660-3576250 chr19:3128790-3131020 chr19:3450190-3452470 chr19:3682640-3685040 chr19:3697880-3700290 chr19:2901050-2903410 chr19:3028800-3028870 chr19:3041080-3043480 chr19:3054040-3054110 chr19:3136590-3138640 chr19:2273490-2274630 chr19:3265270-3265840 chr19:3477300-3478410 chr19:3422730-3424530 chr19:2738220-2739940 chr19:2820120-2821820 chr19:2943210-2944830 chr19:3161140-3161960 chr19:3338310-3339390 chr19:3458510-3460050 chr19:2616550-2617620 chr19:2694300-2696280 chr19:3543470-3543550 chr19:3543680-3543820 chr19:3544030-3544190 chr19:3544730-3544800 chr19:3546420-3547260 chr19:3576300-3576550 chr19:3088850-3089400 chr19:3139660-3141570

Promoter:

chr19:2997637-3047633

 ChIP-seq based regulatory details of TLE2
Sample ID Experiment target Biosample type Biosample term name GSM ID Tissue type Source
 Downstream target genes of TLE2
 Protein-protein interaction of TLE2
OFFICIAL_SYMBOL_A OFFICIAL_SYMBOL_B EXPERIMENTAL_SYSTEM PUBMED_ID ORGANISM_A_ID ORGANISM_B_ID SOURCE
TLE2 TLE2 Reconstituted Complex 9874198 9606 9606 BIOGRID
TLE2 TLE1 Reconstituted Complex 9874198 9606 9606 BIOGRID
TLE2 TLE1 Two-hybrid 9874198 9606 9606 BIOGRID
TLE2 VENTX Two-hybrid 20211142 9606 9606 BIOGRID
TLE2 TLX3 Two-hybrid 20211142 9606 9606 BIOGRID
TLE2 BARHL1 Two-hybrid 20211142 9606 9606 BIOGRID
TLE2 LEF1 Reconstituted Complex 15768032 9606 9606 BIOGRID
TLE2 CCT7 Affinity Capture-MS 24981860 9606 9606 BIOGRID
TLE2 ORF50 Affinity Capture-Western 19939918 9606 37296 BIOGRID
 Annotation of TLE2
 TCGA cancer survival map of TLE2


Calculate the hazards ratio based on Cox PH Model.
Add the 95% CI as dotted line.
Reset Add The plot axis-x order will follow the list.


Calculate the hazards ratio based on Cox PH Model.
We use log2(TPM + 1) for log-scale.
All Add
Reset The plot is based on the datasets of list.


 Disease information of  TLE2